Dennis H. Oh, MD, PhD

Stanford University, Stanford, CA, B.S. June 1985, Chemistry (w/ Honors), Biological Sciences
Stanford University, Stanford, CA, Ph.D., June 1991, Biophysics
Stanford University, Stanford, CA, M.D., June 1993, Medicine

• 1985-1993
  Trainee, Medical Scientist Training Program (MSTP), Stanford University School of Medicine
• 1987-1991
  Graduate student, Biophysics Program, Stanford University
• 1993-1994
  Internship, Department of Medicine, Brigham and Women's Hospital Clinical Fellow in Medicine, Harvard Medical School
• 1994-1998
  Residency, Department of Dermatology, Stanford University School of Medicine
• 1996-2000
  Postdoctoral fellow, Department of Dermatology and Biological Sciences, Stanford University
• 1998-2000
  Clinical Instructor, Department of Dermatology, Stanford University School of Medicine
• 7/00-10/00
  Assistant Adjunct Professor, Department of Dermatology, University of California, San Francisco
• 7/00-present
  Assistant Chief of Dermatology, San Francisco VA Medical Center
• 10/00-present
  Assistant Professor in Residence, Department of Dermatology, University of California, San Francisco
• 1/1/01-7/1/01
  Acting Chief of Dermatology, San Francisco VA Medical Center

• 1983
  American Heart Association Summer Student Research Internship, Lawrence Berkeley Laboratory, University of California at Berkeley
• 1983, 1984
  Korean Honor Scholarship, Republic of Korea
• 1985
  Graduation with Honors (Chemistry) and with Distinction, Stanford University
• 1985
  Firestone Medal for Excellence in Research, Stanford University
• 1985
  Phi Beta Kappa, Stanford University
• 1985
  Phi Lambda Upsilon (Chemistry), Stanford University
• 1985-1992
  National Research Service Award (Medical Scientist Training Program, Stanford University Medical School)
• 1996-1997
  Bank of America-Giannini Foundation Medical Research Fellow
• 1996-1997
  Cancer Research Foundation of America Fellowship
• 1997-2002
  Mentored Clinical Scientist Development Award (K08)
• 2001-2002
  Dermatology Foundation Research Grant
• 2001-2002
  U.C. San Francisco REAC Award
• 2002-2005
  VA Merit Review Entry Program Award

• Oh, D.H.; Boxer, S.G. Stark Effect Spectra of Ru(diimine)32+ Complexes, J. Am. Chem. Soc. 1989, 111, 1130-1131.
• Oh, D.H.; Boxer, S.G. Electrochromism in the near-IR absorption spectra of bridged ruthenium mixed valence complexes, J. Am. Chem. Soc. 1990, 112, 8161-8162.
• Hasagawa, T.; Franzen, S.; Lambright, D.G.; Oh, D.H.; Balasubramaniam, S.; Hedman, B.; Hodgson, K.O. Inclusion of a small molecule in a big cage: Preparation and structure of catena-[catena-(α,ω|diaminooctane) cadmium-μ-tetracyanonickelate]-toluene (1/1), Inorg. Chem. 1991, 30, 1441-1444.
• Oh, D.H.; Sano, M.; Boxer, S.G. Electro-absorption (Stark effect) spectroscopy of mono- and bi-ruthenium charge transfer complexes: Measurements of changes in dipole moments and other electro-optic properties, J. Am. Chem. Soc. 1991, 113, 6880-6890.
• Lin, M.; Hultquist, K.; Oh, D.H.; Hoeffler, W.K.; Bauer, E.A. Inhibition of collagenase type I expression by psoralen-antisense oligonucleotides in dermal fibroblasts, FASEB J. 1995, 9, 1371-1377.
• Oh, D.H.; Stanley, R.J.; Lin, M.; Hoeffler, W.K.; Boxer, S.G.; Berns, M.W.; Bauer, E.A. Two-photon excitation of 4'-hydroxymethyl-4,5',8-trimethylpsoralen, Photochem. Photobiol. 1997, 1, 91-95.
• Oh, D.H.; Lane, A.T.; Turk, A.E.; Kohler, S. A large hemifacial plaque with histopathologic features of trichoepithelioma, J. Am. Acad. Dermatol. 1997, 37, 881-883.
• Oh, D.H.; Hoeffler, W.K. Pharmacologic inhibition of collagenases. In: Hoeffler,W.K. editor. Collagenases. Austin: R.G. Landes Co., pp. 149-170, 1999.
• Oh, D.H.; Eulau D.; McGuire, J.S.; Tokugawa, D.; Kohler, S. Five cases of calciphylaxis and a review of the literature, J. Am. Acad. Dermatol., 1999, 40, 979-987.
• Oh, D.H.; Hanawalt, P.C. Triple helix-forming oligonucleotides target psoralen adducts to specific chromosomal sequences in human cells, Nucleic Acids Res. 1999, 27, 4734-4742.
• Oh, D.H.; Hanawalt, P.C. Binding and reactivity of psoralen linked to triple helix-forming oligonucleotides, Photochem. Photobiol., 2000, 72(3), 298-307.
• Oh, D.H.; King, B.A., Boxer; S.G., Hanawalt, P.C. "Spatially localized generation of nucleotide sequence-specific DNA damage", Proc. Natl. Acad. Sci., 2001, 98, 11271-11276.
• King, B.A.; Oh, D.H.. Spatial control of reactive oxygen species formation in fibroblasts using two-photon excitation, Photochem. Photobiol., 2004, 80, 1-6.
• Oh, D.H.; Yeh K., Differentiating human keratinocytes are deficient in p53 but preserve global nucleotide excision repair responses following ultraviolet radiation, DNA Repair, 2005, 4, 1149-1159.
• Oh, D.H.; Yeh K., Efficient repair of UV-induced DNA damage in terminally differentiated human keratinocytes, In: From DNA Photolesions to Mutations, Skin Cancer and Cell Death (Évelyne Sage, Régen Drouin, and Mahmoud Rouahbia, Eds), Comprehensive Series in Photosciences (D.P. Hader and Guilio Jori, Series Editors, Elsevier), pp. 167-180 (2005).
• Ferguson, B.E.; Oh, D.H., Proficient global nucleotide excision repair in human keratinocytes but not fibroblasts deficient in p53, Cancer Res., 2005, 65, 8723-8729.
• Mogi, S.; Oh, D.H., gamma-H2AX formation in response to interstrand crosslinks requires XPF in human cells, DNA Repair, DNA Repair, 2006, 5, 731-740.